Effect of adding selegeline to levodopa in early, mild Parkinson's disease. Other studies have not shown increased mortality.
Mäki-Ikola
O
O
Kilkku
O
O
Heinonen
E
E
D000978:Antiparkinson Agents / Q000009:adverse effects*; D018849:Controlled Clinical Trials as Topic; D004359:Drug Therapy, Combination; D006801:Humans; D007980:Levodopa / Q000009:adverse effects*; D015201:Meta-Analysis as Topic; D010300:Parkinson Disease / Q000188:drug therapy / Q000401:mortality*; D012642:Selegiline / Q000009:adverse effects*
D000978:Antiparkinson Agents; D012642:Selegiline; D007980:Levodopa